INtestinal Dysbiosis and TRanslocation of Bacteria in Patients Undergoing Surgery
- Disease/Condition
- Surgical Site Infection
- Drug/Device/Intervention
- No Intervention
- Study type
- Observational
- Intervention type
- other
- Primary sponsor
- University Hospital Inselspital, Berne
- Location
- Bern, Switzerland
- Phase
- N/A
- Start date
- Feb 27, 2023
- End date
- Dec 31, 2026
- Enrollment
- 120 participants
Changes of the intestinal microbiome between start and end of surgery
The goal of this observational study is to contribute to a better understanding of the
 perioperative kinetics of intestinal microbial composition and association with surgical site
 infections.
 
 The main question this study aims to determine if:
 
 - Patients undergoing surgery develop transient intestinal dysbiosis
 
 - Such transient dysbiosis is associated with translocation to the systemic circulation
 and surgical site infection
 
 Patients undergoing elective abdominal surgery will be included prospectively. Informed
 consent will be obtained. From patients the following information and samples will be
 collected:
 
 - Perioperative: Baseline health data, nutrition data, measurement body composition,
 glucose monitoring
 
 - Intraoperatively:
 
 - Mucosal swabs
 
 - Blood from central venous catheter and portal vein
 
 - Mesenteric lymph node
 
 - Intestinal specimen
 
 - Subcutaneous biopsy
 
 - Postoperatively:
 
 - If a surgical site infection occurs samples from infected site
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05775341
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05775341 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital Inselspital, Berne and is currently Recruiting. The study focuses on Surgical Site Infection. Target enrollment is 120 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.